Skip to content

Sjogren’s Treatment Report

www.SjogrensTreatmentReport.com

  • News
  • Research
  • Clinical Trials
  • Discussion
Menu
  • News
  • Research
  • Clinical Trials
  • Discussion

Pending

  • 2021 recommendations of the Brazilian Society of Rheumatology for the gynecological and obstetric care of patients with Sjogren’s syndrome
  • Tetrahedral Framework Nucleic Acids Reestablish Immune Tolerance and Restore Saliva Secretion in a Sjogren’s Syndrome Mouse Model
  • Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review
  • Successful Treatment of Sjogren-Associated Interstitial Lung Disease With Rituximab
  • Rheumatoid arthritis, systemic lupus erythematosus and primary Sjogren’s syndrome shared megakaryocyte expansion in peripheral blood
  • Sex Differences in Otolaryngology: Focus on the Emerging Role of Estrogens in Inflammatory and Pro-Resolving Responses
  • Characterization of Lipids in Saliva, Tears and Minor Salivary Glands of Sjogren’s Syndrome Patients Using an HPLC/MS-Based Approach
  • Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjogren’s syndrome by modulating the balance of Treg and Th17 cells
  • Characterization of comprehensive dynamic epigenetic changes during human primary Sjogren’s syndrome progression
  • A rare case of pulmonary nocardiosis comorbid with Sjogren’s syndrome
  • Comparative analysis of the efficacy and safety of herbal decoction CheReCunJin alone and combined with hydroxychloroquine for treating primary Sjogren’s syndrome: A randomized controlled trial
  • Pilocarpine
  • Association of the Risk of Childhood Asthma at Age 6 With Maternal Allergic or Immune-Mediated Inflammatory Diseases: A Nationwide Population-Based Study
  • Effect of topical injection of cyclosporine A on saliva secretion and inflammation in the submandibular gland of non-obese diabetic mice
  • Improvement of constrictive bronchiolitis (bronchiolitis obliterans) after rituximab therapy in 2 patients with primary sjogren syndrome
  • Pulmonary involvement in Sjogren’s syndrome
  • A Case of Sjogren’s Syndrome with Pleural Effusion: Difficult to Distinguish from Tuberculous Pleurisy Because of a High Adenosine Deaminase Level
  • Autonomic Nervous System Dysfunction in Primary Sjogren’s Syndrome
  • Sjogren’s syndrome
  • Autoantibodies in Patients With Immune-Related Adverse Events From Checkpoint Inhibitors: A Systematic Literature Review
  • Association between increased Bcl-2, Fas and FasL levels and inflammation extent in labial salivary glands during primary Sjogren’s syndrome
  • Characteristics and Management of Autoimmune Disease-Associated Cerebral Venous Sinus Thrombosis
  • In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma
  • Salivary Gland Tissue Engineering Approaches: State of the Art and Future Directions
  • Atypical presentation of Sjogren’s syndrome with MALT lymphoma mimicking chronic venous ulcers
  • Cf-02, a novel benzamide-linked small molecule, blunts NF-κB activation and NLRP3 inflammasome assembly and improves acute onset of accelerated and severe lupus nephritis in mice
  • Biological Therapy in Primary Sjogren’s Syndrome: Effect on Salivary Gland Function and Inflammation
  • DNA Methylation-Based Interferon Scores Associate With Sub-Phenotypes in Primary Sjogren’s Syndrome
  • Tear metabolomics highlights new potential biomarkers for differentiating between Sjogren’s syndrome and other causes of dry eye
  • Aquaporin5-Targeted Treatment for Dry Eye Through Bioactive Compounds and Gut Microbiota
  • The transcriptome of rabbit conjunctiva in dry eye disease: Large-scale changes and similarity to the human dry eye
  • An update of targeted therapeutic options for primary Sjogren syndrome: current status and future development
  • Shared Pathogenetic Features Between Common Variable Immunodeficiency and Sjogren’s Syndrome: Clues for a Personalized Medicine
  • Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases
  • Surgical resection of pulmonary crystal-storing histiocytosis with Sjogren’s syndrome: A case report
  • The evaluation of lung involvement and functional capacities in patients diagnosed with primary sjogren’s syndrome
  • The Transcriptome of Paired Major and Minor Salivary Gland Tissue in Patients With Primary Sjogren’s Syndrome
  • Update on the application of amniotic membrane in immune-related ocular surface diseases
  • Treatment strategies for Sjogren’s syndrome with childhood onset: a systematic review of the literature
  • Metformin as a Treatment Strategy for Sjogren’s Syndrome
  • Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus
  • Efficacy and safety of Tripterygium glycosides in Sjogren’s syndrome treatment: evidence from 12 randomized controlled trials
  • Efficacy of hydroxychloroquine for treating annular erythema associated with Sjogren’s syndrome
  • Rituximab for the treatment of acute onset Interstitial Lung Disease in primary Sjogren’s syndrome
  • Understanding Fatigue in Sjogren’s Syndrome: Outcome Measures, Biomarkers and Possible Interventions
  • From Hypokalemic Crisis to Sjogren’s Syndrome: A Case Report and Literature Review
  • Ocular Manifestations in Colombian Patients with Systemic Rheumatologic Diseases
  • Novel Multidisciplinary Salivary Gland Society (MSGS) Questionnaire: An International Consensus
  • IFN-α: a key therapeutic target for multiple autoimmune rheumatic diseases
  • Xerostomia
  • Combined Low-Level Light Therapy and Intense Pulsed Light Therapy for the Treatment of Dry Eye in Patients with Sjogren’s Syndrome
  • The PI3Kdelta inhibitor parsaclisib ameliorates pathology and reduces autoantibody formation in preclinical models of systemic lupus erythematosus and Sjgren’s syndrome
  • Effect of the Chinese Herbal Medicine SS-1 on a Sjogren’s Syndrome-Like Disease in Mice
  • A Review of Topical and Systemic Vitamin Supplementation in Ocular Surface Diseases
  • Instruments for Outcome Evaluation of Specific Domains in Primary Sjogren’s Syndrome
  • Protective effects of miR-155-5p silencing on IFN-γ-induced apoptosis and inflammation in salivary gland epithelial cells
  • Current and future therapies for primary Sjogren syndrome
  • Sjogren’s syndrome with nervous system injury combined with pulmonary and osseous cryptococcosis: a case report
  • The Multiple Roles of B Cells in the Pathogenesis of Sjogren’s Syndrome
  • Revisiting the JOQUER trial: stratification of primary Sjogren’s syndrome and the clinical and interferon response to hydroxychloroquine
  • Management of Sjogren’s Syndrome: Present Issues and Future Perspectives
  • The ratio of neutrophil to lymphocyte predicts interstitial lung disease and its prognosis in patients with primary Sjogren’s syndrome: a retrospective analysis
  • Integrated Analysis of Transcriptomics to Identify Hub Genes in Primary Sjogren’s Syndrome
  • Effectiveness of Distance Technology in Promoting Physical Activity in Cardiovascular Disease Rehabilitation: Cluster Randomized Controlled Trial, A Pilot Study
  • TAZ inhibits acinar cell differentiation but promotes immature ductal cell proliferation in adult mouse salivary glands
  • Corrigendum to “Health-Related Quality of Life and Sleep Quality after 12 Months of Treatment in Nonsevere Obstructive Sleep Apnea: A Randomized Clinical Trial with Continuous Positive Airway Pressure and Mandibular Advancement Splints”
  • A Review of the Efficacy of Influenza Vaccination in Autoimmune Disease Patients
  • Autologous versus allogeneic versus umbilical cord sera for the treatment of severe dry eye disease: a double-blind randomized clinical trial
  • Impact of the COVID-19 pandemic on eye strain and dry eye symptoms
  • Intrathecal drug delivery to treat intractable neuropathic pain following Sjogren’s syndrome-induced transverse myelitis: A case report
  • The other connective tissue disease-associated interstitial lung diseases: Sjogren’s syndrome, mixed connective tissue disease, and systemic lupus erythematosus
  • Drug-induced toxidermia in a patient receiving hydroxychloroquine as systemic therapy for primary Gougerot-Sjogren syndrome: a case report
  • Cholinergic anti-inflammatory pathway and connective tissue diseases
  • A new molecular classification to drive precision treatment strategies in primary Sjogren’s syndrome
  • Primary Sjogren’s Syndrome: A Retrospective Cohort Study of Burden of Illness in Sweden
  • Relationships between activated dendritic cells and dry eye symptoms and signs
  • Sjogren’s syndrome: a systemic autoimmune disease
  • Case Report: Anti-N-Methyl-D-Aspartate Receptor Encephalitis in an Elderly Patient With Primary Sjogren’s Syndrome
  • Increased CD4(+)CD8(+) Double-Positive T Cell in Patients with Primary Sjogren’s Syndrome Correlated with Disease Activity
  • Resilience in women with primary Sjogren’s syndrome
  • Ocular cicatricial pemphigoid: Methotrexate as an initial treatment?
  • Early-Onset Cardiomyopathy After Pacemaker Implanted in a Preterm Infant With Congenital Complete Heart Block and Anti-Ro/SSA Antibodies
  • B cells as target for immunotherapy in rheumatic diseases – current status
  • Characterization of Extracellular Vesicle Cargo in Sjogren’s Syndrome through a SWATH-MS Proteomics Approach
  • Pain and fatigue are predictors of quality of life in primary Sjogren’s syndrome
  • Sjogren’s syndrome with adult-onset Still’s disease: an overlap syndrome?
  • The complex role of AIM2 in autoimmune diseases and cancers
  • Adipose-mesenchymal stromal cells suppress experimental Sjogren syndrome by IL-33-driven expansion of ST2(+) regulatory T cells
  • Application of regenerative medicine to salivary gland hypofunction
  • Is Sjogren’s syndrome a risk factor/contraindication for dental implants? An umbrella review
  • Atypical posterior reversible encephalopathy syndrome in a case of thrombotic thrombocytopenic purpura with Sjogren’s syndrome
  • Long-term opioid treatment and endocrine measures in chronic non-cancer pain patients: A systematic review and meta-analysis
  • Corneal nerve structure in patients with primary Sjogren’s syndrome in China
  • Significance of Sjogren’s syndrome and anti-cN1A antibody in myositis patients
  • Emerging role of galectin family in inflammatory autoimmune diseases
  • Autoimmune B Cell Repertoire in a Mouse Model of Sjogren’s Syndrome
  • Functionally selective and biased agonists of muscarinic receptors
  • Exploring the role of immunotherapeutic drugs in autoimmune diseases: A comprehensive review
  • Go Ask Your Patients! PSS-QoL Reported Perception of Dryness Correlates With Lacrimal and Salivary Flow in Primary Sjogren’s Syndrome
  • Intratracheal Poly(I:C) Exposure Accelerates the Immunological Disorder of Salivary Glands in Sjogren’s-Like NOD/ShiLtJ Mice
  • Musculoskeletal Manifestations in Sjogren’s Syndrome: An Orthopedic Point of View
  • Clinical features and risk factors of Raynaud’s phenomenon in primary Sjogren’s syndrome
  • Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an Update for the Rheumatologist
  • Hypomethylation mediates genetic association with the major histocompatibility complex genes in Sjogren’s syndrome
  • Sporadic inclusion body myositis and primary Sjogren’s syndrome: an overlooked diagnosis
  • Patients with early-onset primary Sjogren’s syndrome have distinctive clinical manifestations and circulating lymphocyte profiles
  • Acute motor and sensory axonal neuropathy in association with primary Sjogren’s syndrome: a case report
  • Lycium barbarum Polysaccharide Ameliorates Sjogren’s Syndrome in a Murine Model
  • Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjogren’s syndrome
  • Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib
  • Effectiveness and Safety of Iguratimod in Treating Primary Sjogren’s Syndrome: A Systematic Review and Meta-Analysis
  • Formation of Autoimmune Lesions Is Independent of Antibiotic Treatment in NOD Mice
  • Response to: ‘Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial” by de Wolff et al
  • The Enduring Experience in Dry Eye Diagnosis: A Non-Interventional Study Comparing the Experiences of Patients Living With and Without Sjogren’s Syndrome
  • Atypical Sjogren’s Syndrome Initially Presenting as Lymphocytic Interstitial Pneumonitis followed by Immune Thrombocytopenia
  • Sjogren’s Syndrome and Pulmonary Disease
  • Rabbit models of dry eye disease: Current understanding and unmet needs for translational research
  • Mesenchymal stromal cells for the treatment of ocular autoimmune diseases
  • Activation of Toll-Like Receptor 7 Signaling Pathway in Primary Sjogren’s Syndrome-Associated Thrombocytopenia
  • Glomerulonephritis with severe nephrotic syndrome induced by immune complexes composed of galactose-deficient IgA1 in primary Sjogren’s syndrome: a case report
  • Coexistence of Sjogren syndrome in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A retrospective observational study
  • Evaluation of Asymptomatic Bacteriuria and Urinary Tract Infection in Patients With Primary Sjogren’s Syndrome
  • Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised controlled trial’
  • Pathology of salivary gland dysfunction and restoration of function
  • S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-alpha) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases
  • Secreted factors from dental pulp stem cells improve Sjogren’s syndrome via regulatory T cell-mediated immunosuppression
  • Muscle Tone Assessment under General Anesthesia for Sjogren-Larsson Syndrome and Spasticity
  • Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system
  • The relationship between Sjogren’s syndrome, systemic sclerosis and lymphoproliferative diseases
  • Juvenile primary Sjogren’s syndrome with cutaneous involvement
  • Salivary dysbiosis in Sjogren’s syndrome and a commensal-mediated immunomodulatory effect of salivary gland epithelial cells
  • Reactivity of human labial glands in response to cevimeline treatment
  • A Novel Approach for Immediate Implant-based Oral Rehabilitation in a Sjogren’s Syndrome Patient Using Virtual Surgical and Prosthetic Planning
  • Sjogren’s syndrome: from diagnosis to treatment
  • MTH1 inhibitors for the treatment of psoriasis
  • Chemokines Up-Regulated in Epithelial Cells Control Senescence-Associated T Cell Accumulation in Salivary Glands of Aged and Sjogren’s Syndrome Model Mice
  • What is the evidence that mycobacteria are associated with the pathogenesis of Sjogren’s syndrome?
  • Not all Sicca is Sjogren’s and not all Sjogren’s is Sicca
  • Dental pulp-derived stem cell-conditioned media attenuates secondary Sjogren’s syndrome via suppression of inflammatory cytokines in the submandibular glands
  • Severe pulmonary arterial hypertension and massive ascites in a patient with systemic lupus erythematosus and secondary Sjogren’s syndrome
  • Deciphering potential pharmacological mechanism of Sha-Shen-Mai-Dong decoction on primary Sjogren’s syndrome
  • Two shared immune cell signatures stratify patients with Sjogren’s syndrome and systemic lupus erythematosus with potential therapeutic implications
  • Effects of cyclophosphamide and rituximab in patients with connective tissue diseases with severe interstitial lung disease
  • Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis
  • Transduction of Salivary Gland Acinar Cells with a Novel AAV Vector 44.9
  • The Impact of SARS-CoV-2 Outbreak on Primary Sjogren’s Syndrome: An Italian Experience
  • Primary Sjogren’s syndrome manifesting as sclerotic metabolic bone disease
  • Analysis of non-tuberculous mycobacterial lung disease in patients with primary Sjogren’s syndrome at a referral center
  • Lymphocyte subpopulations in Sjogren’s syndrome are distinct in anti-SSA-positive patients and related to disease activity
  • MicroRNA-146a-5p enhances T helper 17 cell differentiation via decreasing a disintegrin and metalloprotease 17 level in primary sjogren’s syndrome
  • Primary Sjogren syndrome increases the risk of bisphosphonate-related osteonecrosis of the jaw
  • Ocular Cicatricial Pemphigoid: Methotrexate as an Initial Treatment?
  • Anti-mitochondrial Antibodies in Patients with Dilated Cardiomyopathy
  • Immune Monitoring upon Treatment with Biologics in Sjogren’s Syndrome: The What, Where, When, and How
  • Lacrimal gland atrophy and dry eye related to isotretinoin, androgen, and prolactin: differential diagnosis for Sjogren’s syndrome
  • Neonatal lupus erythematosus – practical guidelines
  • Correction: Abughanam, G., et al. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren’s Syndrome-Like Disease. Int. J. Mol. Sci. 2019, 20, 4750
  • New frontiers in precision medicine for Sjogren’s syndrome
  • Interleukin 1alpha: a comprehensive review on the role of IL-1alpha in the pathogenesis and treatment of autoimmune and inflammatory diseases
  • Topical cyclosporine a (0.05%) treatment in dry eye patients: a comparison study of Sjogren’s syndrome versus non-Sjogren’s syndrome
  • Systemic diseases and the cornea
  • Transcriptomic and Network Analysis of Minor Salivary Glands of Patients With Primary Sjogren’s Syndrome
  • A Case of Repeated TAFRO Syndrome-Like Symptoms and Retroperitoneal Hemorrhage in a Patient With Sjogren Syndrome
  • Response to: ‘Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial” by Wang et al
  • Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial’
  • Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
  • Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review
  • Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
  • Asymptomatic Lymphocytic Interstitial Pneumonia with Extensive HRCT Changes Preceding Sjogren’s Syndrome
  • Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren’s syndrome: A review
  • Normal salivary gland ultrasonography could rule out the diagnosis of Sjogren’s syndrome in anti-SSA-negative patients with sicca syndrome
  • Knockdown of RSAD2 attenuates B cell hyperactivity in patients with primary Sjogren’s syndrome (pSS) via suppressing NF-kappab signaling pathway
  • Refractory IgG4-related Pleural Disease with Chylothorax: A Case Report and Literature Review
  • Mild stimulatory effect of a probiotic mix on bone mass when treatment is initiated 1.5 weeks after ovariectomy in mice
  • Evaluation of the effect of topical tacrolimus 0.03% versus cyclosporine 0.05% in the treatment of dry eye secondary to Sjogren syndrome
  • CD8(+) T Lymphocytes: Crucial Players in Sjogren’s Syndrome
  • Association between nucleos(t)ide analogue therapy for hepatitis B and Sjogren’s syndrome: 15-year analysis of the national database of Taiwan
  • Role of the HSP70 Co-Chaperone SIL1 in Health and Disease
  • Allogeneic and autologous serum eye drops: a pilot double-blind randomized crossover trial
  • SS-A52 antigen expression in thymic carcinoma accompanied with Sjogren syndrome: A case report
  • P2Y(2) receptor antagonism resolves sialadenitis and improves salivary flow in a Sjogren’s syndrome mouse model
  • Correction to: Treatment of acute Achilles tendon rupture – a multicentre, non-inferiority analysis
  • A Case of Immune-Mediated Necrotizing Myopathy Associated with Primary Sjogren Syndrome
  • A case report of Mikulicz’s disease
  • The Role of Interferons in the Pathogenesis of Sjogren’s Syndrome and Future Therapeutic Perspectives
  • Ocular Cicatricial Pemphigoid, Sjogren’s Syndrome, and Hashimoto’s Thyroiditis as a Multiple Autoimmune Syndrome: A case report
  • EULAR Sjögren’s syndrome study group: an eSSential way to address the unmet needs of the disease.
  • Neonatal lupus presenting as a non-specific rash in primary care.
  • Ocular Cicatricial Pemphigoid, Sjögren’s Syndrome, and Hashimoto’s Thyroiditis as a Multiple Autoimmune Syndrome: A case report.
  • Differences in clinical features between small fiber and sensitive large fiber neuropathies in Sjögren’s syndrome.
  • CD8+ T Lymphocytes: Crucial Players in Sjögren’s Syndrome.
  • Primary Sjogren’s syndrome manifesting with distal renal tubular acidosis and severe metabolic bone disease.
  • The Role of Interferons in the Pathogenesis of Sjögren’s Syndrome and Future Therapeutic Perspectives.
  • Epidemiology of Non-Hodgkin’s Lymphoma.
  • Neonatal lupus erythematosus presenting with rash, thrombocytopenia compounded by cytomegalovirus colonisation: a diagnostic dilemma.
  • [A Case of Immune-Mediated Necrotizing Myopathy Associated with Primary Sjögren Syndrome].
  • Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjogren’s syndrome patients: case series study and review of the literature.
  • Prevalence and clinical presentation of lymphoproliferative disorder in patients with primary Sjögren’s syndrome.
  • P2Y2 receptor antagonism resolves sialadenitis and improves salivary flow in a Sjögren’s syndrome mouse model.
  • Association between nucleos(t)ide analogue therapy for hepatitis B and Sjögren’s syndrome: 15-year analysis of the national database of Taiwan.
  • Vagus nerve stimulation in musculoskeletal diseases.
  • Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases.
  • Sicca syndrome following immune checkpoint inhibition.
  • Hydroxychloroquine in systemic and auto-immune diseases: where are we now?
  • Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren’s syndrome: A review.
  • Knockdown of RSAD2 attenuates B cell hyperactivity in patients with primary Sjögren’s syndrome (pSS) via suppressing NF-κb signaling pathway.
  • Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications.
  • Asymptomatic Lymphocytic Interstitial Pneumonia with Extensive HRCT Changes Preceding Sjogren’s Syndrome.
  • Characteristics of diffuse large B-cell lymphoma in patients with primary Sjögren’s syndrome.
  • Response to: ‘Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial” by Wang et al.
  • Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial’.
  • COVID-19 in Italian Sjögren’s syndrome patients: a monocentric study.
  • Transcriptomic and Network Analysis of Minor Salivary Glands of Patients With Primary Sjögren’s Syndrome.
  • Topical cyclosporine a (0.05%) treatment in dry eye patients: a comparison study of Sjogren’s syndrome versus non-Sjogren’s syndrome.
  • Correction: Abughanam, G., et al. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren’s Syndrome-Like Disease. Int. J. Mol. Sci. 2019, 20, 4750.
  • A patient with primary Sjogren’s syndrome, cystic lung disease, and MALT lymphoma treated successfully with rituximab: a case-based review.
  • Immune Monitoring upon Treatment with Biologics in Sjögren’s Syndrome: The What, Where, When, and How.
  • Lacrimal gland atrophy and dry eye related to isotretinoin, androgen, and prolactin: differential diagnosis for Sjögren’s syndrome.
  • Neonatal lupus erythematosus – practical guidelines.
  • Mechanism of cAMP-PKA Signaling Pathway Mediated by Shaoyao Gancao Decoction () on Regulation of Aquaporin 5 and Muscarinic Receptor 3 Levels in Sjögren’s Syndrome.
  • Clinical characteristics of systemic lupus erythematosus with chylothorax and/or chylous ascites: An analysis of 15 cases in China.
  • Subacute cutaneous lupus erythematosus in a patient with Sjögren’s syndrome taking terbinafine for onychomycosis.
  • Ocular Cicatricial Pemphigoid: Methotrexate as an Initial Treatment?
  • Why is a paediatric respiratory specialist integral to the paediatric rheumatology clinic?
  • MicroRNA-146a-5p enhances T helper 17 cell differentiation via decreasing a disintegrin and metalloprotease 17 level in primary sjögren’s syndrome.
  • Lymphocyte subpopulations in Sjögren’s syndrome are distinct in anti-SSA-positive patients and related to disease activity.
  • Analysis of non-tuberculous mycobacterial lung disease in patients with primary Sjögren’s syndrome at a referral center.
  • Primary Sjögren’s syndrome manifesting as sclerotic metabolic bone disease.
  • The Impact of SARS-CoV-2 Outbreak on Primary Sjögren’s Syndrome: An Italian Experience.
  • Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies.
  • Suppression of high-mobility group box 1 ameliorates xerostomia in a Sjögren syndrome-triggered mouse model.
  • Mesenchymal Stem Cell Enhances the Function of MDSCs in Experimental Sjögren Syndrome.
  • [CAI Sheng-chao’s experience in treatment of Sjögren’s syndrome with moxibustion for promoting meridian circulation and warming yang].
  • Interleukin-22 and connective tissue diseases: emerging role in pathogenesis and therapy.
  • Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients.
  • Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren’s syndrome by modulating the function of myeloid-derived suppressor cells.
  • Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis.
  • Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren’s syndrome or systemic lupus erythematosus.
  • Haematologic Indices And Disease Activity Index In Primary Sjogren’s Syndrome.
  • [Change of diagnosis and diagnostic category in patients with juvenile idiopathic arthritis within 7 years of follow-up].
  • B7-H3: A promising therapeutic target for autoimmune diseases.
  • Alleviating effect of paeoniflorin-6′-O-benzene sulfonate in antigen-induced experimental Sjögren’s syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK/p38 signaling pathway.
  • High-Fat Diet-Induced Functional and Pathologic Changes in Lacrimal Gland.
  • New developments in esophageal function testing and esophageal manifestations of connective tissue disorders.
  • Intralacrimal Sustained Delivery of Rapamycin Shows Therapeutic Effects without Systemic Toxicity in a Mouse Model of Autoimmune Dacryoadenitis Characteristic of Sjögren’s Syndrome.
  • Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management.
  • Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment.
  • Renal Disease in Primary Sjögren’s Syndrome.
  • Systematic review of safety and efficacy of belimumab in treating immune-mediated disorders.
  • What’s new in ocular and oral aspects of Sjögren’s syndrome and do new treatments work?
  • Association of salivary inflammatory biomarkers with primary Sjögren’s syndrome.
  • Beyond the joints, the extra-articular manifestations in rheumatoid arthritis.
  • Transcranial Direct Current Stimulation for Fatigue in Patients with Sjogren’s Syndrome: a Randomized, Double-blind Pilot Study.
  • Association Between Early Sjögren Markers and Symptoms and Signs of Dry Eye.
  • Community-acquired Klebsiella pneumoniae central nervous system infection after acute suppurative otitis.
  • Salivary Glands and Periodontal Changes in a Population of Sjögren’s and Sicca Syndrome Treated by Pilocarpine: A Pilot Study.
  • Targeted therapies in interstitial lung disease secondary to systemic autoimmune rheumatic disease. Current status and future development.
  • Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sjögren’s syndrome.
  • The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus.
  • Environmental factors in the pathogenesis of primary Sjögren’s syndrome.
  • Proximal Muscle Weakness With Overlying Hypokalemic Periodic Paralysis in Sjögren Syndrome: Report of 6 Cases.
  • Primary Sjögren’s Syndrome and Cardiovascular Disease.
  • The impact of primary Sjogren’s syndrome on female sexual function.
  • Salivary Gland Mucosa-Associated Lymphoid Tissue-Type Lymphoma From Sjögren’s Syndrome Patients in the Majority Express Rheumatoid Factors Affinity-Selected for IgG.
  • Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?
  • Early diagnosis and treatment for Sjögren’s syndrome: current challenges, redefined disease stages and future prospects.
  • Sjögren’s Syndrome Associated With Thrombotic Thrombocytopenic Purpura: A Case-Based Review.
  • A Presentation of Pediatric Sjögren’s Syndrome with Abducens Nerve Palsy.
  • [Primary diffuse large B-cell lymphoma of the breast in a male patient with Sjögren’s syndrome].
  • Transduction of Salivary Gland Acinar Cells with a Novel AAV Vector 44.9.
  • Idiopathic multicentric Castleman disease with Sjögren’s syndrome and secondary membranous nephropathy: a case report and review of the literature.
  • Innate Immunity and Biological Therapies for the Treatment of Sjögren’s Syndrome.
  • Secretome Analysis of Inductive Signals for BM-MSC Transdifferentiation into Salivary Gland Progenitors.
  • Clinical features and outcomes from the Singapore Sjögren’s syndrome study.
  • Increased expression of interleukin-21-inducible genes in minor salivary glands are associated with primary Sjögren’s syndrome disease characteristics.
  • Releasing the brakes: a case report of pulmonary arterial hypertension induced by immune checkpoint inhibitor therapy.
  • Macrophage activation syndrome in a patient with systemic lupus erythematosus (SLE) and dual viremia.
  • Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A Systematic Review.
  • Sjögren’s syndrome with rapidly progressive motor neuron disease: a case report.
  • The Prevalence of Sjögren’s Syndrome in Rheumatoid Arthritis Patients and Their Clinical Features.
  • Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren’s syndrome-associated dry eyes.
  • Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus.
  • Inhibition of bone morphogenetic protein 6 receptors ameliorates Sjögren’s syndrome in mice.
  • Ganglionic Acetylcholine Receptor Antibodies and Autonomic Dysfunction in Autoimmune Rheumatic Diseases.
  • Recurrent optic neuritis in a patient with Sjogren syndrome and neuromyelitis optica spectrum disorder: A case report.
  • [Renal involvement in Sjögren’s syndrome].
  • Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.
  • A Case of Prolonged Catatonia Caused by Sjögren’s Syndrome.
  • Allergic diseases and long-term risk of autoimmune disorders: longitudinal cohort study and cluster analysis.
  • Chemosensory dysfunction, Oral disorders and Oral health-related quality of life in patients with primary Sjögren’s syndrome: comparative cross-sectional study.
  • Sirolimus for patients with connective tissue disease-related refractory thrombocytopenia: a single-arm, open-label clinical trial.
  • Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically Based Pharmacokinetic Modeling.
  • Successful Treatment of Urticarial Vasculitis in a Patient With Systemic Lupus Erythematosus With Rituximab.
  • Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases.
  • T Cells Subsets in the Immunopathology and Treatment of Sjogren’s Syndrome.
  • Effects of Anti-Helicobacter pylori Therapy on Incidence of Autoimmune Diseases, Including Inflammatory Bowel Diseases.
  • Risk factors of attacks in neuromyelitis optica spectrum disorders.
  • Tracheobronchial amyloidosis in primary Sjögren syndrome: A case report.
  • Efficacy and safety of abatacept in active primary Sjögren’s syndrome: results of a phase III, randomised, placebo-controlled trial.
  • [Dry mouth. Case histories from a saliva clinic].
  • Interferon-stimulated GTPases in autoimmune and inflammatory diseases: promising role for the guanylate-binding protein (GBP) family.
  • Unusual Presentation of Polyautoimmunity and Renal Tubular Acidosis in an Adolescent With Hashimoto’s Thyroiditis and Central Pontine Myelinolysis.
  • Cytokines and Fatigue in Sjogren’s Syndrome: An Evolving Landscape.
  • Office-based salivary gland ductal irrigation in patients with chronic sialoadenitis: A preliminary study.
  • Sjögren syndrome associated with protein-losing enteropathy: case-based review.
  • Burden of illness among subgroups of patients with primary Sjögren’s syndrome and systemic involvement.
  • Catalpol ameliorates Sjögren’s Syndrome by modulating interplay of T and B cells.
  • Sialendoscopy and Sjogren’s Disease: A Systematic Review.
  • Neuromyelitis optica spectrum disorder complicated with Sjögren’s syndrome: first pediatric case responsive to mycophenolate mofetil treatment.
  • Cardiovascular Protection of Hydroxychloroquine in Patients with Sjögren’s Syndrome.
  • Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis.
  • Identification of Long Noncoding RNAs lnc-DC in Plasma as a New Biomarker for Primary Sjögren’s Syndrome.
  • Variability of salivary metabolite levels in patients with Sjögren’s syndrome.
  • Efficacy and safety of iguratimod on patients with primary Sjögren’s syndrome: a randomized, placebo-controlled clinical trial.
  • Composite Epstein-Barr virus-positive mucosa-associated lymphoid tissue lymphoma and Epstein-Barr virus-negative diffuse large B-cell lymphoma in the parotid salivary gland of a patient with Sjögren’s syndrome and rheumatoid arthritis: a case report.
  • Serious infections in Sjögren’s syndrome patients: a national U.S. study.
  • Type-III interferons in Sjögren’s syndrome.
  • A Training Tool to support the management and diagnosis of Sjögren’s syndrome.
  • One year in review 2020: pathogenesis of primary Sjögren’s syndrome.
  • Ianalumab (VAY736) in primary Sjögren’s syndrome: assessing disease activity using multi-modal ultrasound.
  • Pathogenesis of primary Sjögren’s syndrome beyond B lymphocytes.
  • Mediterranean diet and risk of Sjögren’s syndrome.
  • Biologic therapy in Sjögren’s syndrome.
  • Evaluation of lymphocytic infiltration in the bronchial glands of Sjögren’s syndrome in transbronchial lung cryobiopsy.
  • A Fast and Clean BTK Inhibitor.
  • Treatment of primary sjögren’s syndrome-related interstitial lung disease: a retrospective cohort study.
  • Clinically significant renal involvement in primary Sjögren’s syndrome is associated with important morbidity: data from the Spanish Sjögrenser cohort.
  • What about glucocorticoids in primary Sjögren’s syndrome?
  • Interstitial lung disease in Sjögren’s syndrome: a clinical review.
  • Blocking T cell co-stimulation in primary Sjögren’s syndrome: rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers.
  • Primary Sjögren’s syndrome: central and peripheral nervous system involvements.
  • Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren’s Syndrome.
  • A case report, a case who developed limited cutaneous scleroderma and pulmonary hypertension 8 years after diagnosis of anti-centromere antibody-positive Sjögren syndrome.
  • Distal Renal Tubular Acidosis in Sjögren’s Syndrome: A Case Report.
  • Fitness for purpose of routinely recorded health data to identify patients with complex diseases: The case of Sjögren’s syndrome.
  • Reduced salivary flow and caries status are correlated with disease activity and severity in patients with diffuse cutaneous systemic sclerosis.
  • Artesunate inhibits Sjögren’s syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
  • Pulmonary Manifestations of Primary Sjögren’s Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management.
  • Small trial with short duration does not provide evidence that probiotics reduce the risk of developing oral candidiasis in patients with Sjögren syndrome.
  • Development and exacerbation of pulmonary nontuberculous mycobacterial infection in patients with systemic autoimmune rheumatic diseases.
  • Interleukin-7/Interferon axis drives T-cell and salivary gland epithelial cell interactions in Sjögren’s syndrome.
  • Fingolimod reduces salivary infiltrates and increases salivary secretion in a murine Sjögren’s model.
  • Mycophenolate for the Treatment of Primary Sjögren’s Syndrome.
  • B7-H4 Inhibits the Development of Primary Sjögren’s Syndrome by Regulating Treg Differentiation in NOD/Ltj Mice.
  • Takotsubo syndrome and rheumatic diseases-a critical systematic review.
  • Cytokine profiles and clinical characteristics in primary Sjögren´s syndrome patient groups.
  • Pilocarpine for Sjögren’s Syndrome-Induced Dry Mouth and Dry Eyes: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
  • Pilocarpine for Radiotherapy-Induced Dry Mouth and Dry Eyes: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
  • Clinical profile and associated factors of pulmonary involvement in primary Sjögren’s syndrome.
  • [Analysis of clinical features and prognosis in patients with primary Sjögren’s syndrome and autoimmune liver disease].
  • [Nasal manifestations of Sjogren’s syndrome].
  • Biomarkers and Diagnostic Testing for Renal Disease in Sjogren’s Syndrome.
  • Stem cell treatments for oropharyngeal dysphagia: Rationale, benefits, and challenges.
  • Checkpoint inhibition-induced sicca: a type II interferonopathy?
  • Comorbidity and health care utilisation in persons with Sjögren’s syndrome: a claims data analysis.
  • Compromised ultrasound remission, functional ability and clinical decision associated with overlapping Sjögren’s syndrome in rheumatoid arthritis patients: results from a propensity-score matched cohort from 2009 to 2019.
  • Characterisation of articular manifestations in primary Sjögren’s syndrome: clinical and imaging features.
  • T cell lymphoma in the setting of Sjögren’s syndrome: T cells gone bad? Report of five cases from a single centre cohort.
  • Primary Sjögren’s Syndrome Accompanied by Clinical Features of TAFRO Syndrome.
  • Comparison of Rituximab Originator With CT-P10 Biosimilar in Patients With Primary Sjögren’s Syndrome: A Retrospective Analysis in a Real-Life Setting.
  • sPLA2-IIa participates in ocular surface inflammation in humans with dry eye disease.
  • [Immune disorders associated with juvenile recurrent chronic parotitis].
  • Clinical phenotyping of primary Sjögren’s patients using salivary gland ultrasonography – data from the RESULT cohort.
  • Innate immune response in systemic autoimmune diseases: a potential target of therapy.
  • Intraoperative visualisation and treatment of salivary glands in Sjögren’s syndrome by contrast-enhanced ultrasound sialendoscopy (CEUSS): protocol for a phase I single-centre, single-arm, exploratory study.
  • Biologics in the treatment of Sjogren’s syndrome, systemic lupus erythematosus, and lupus nephritis.
  • Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases.
  • Myasthenia Gravis Coexisting With Primary Sjögren’s Syndrome: Report of Three Cases and Literature Review.
  • Bipolar Disorder as Comorbidity with Sjögren’s Syndrome: What Can We Do?
  • Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
  • Recurrent breast amyloidosis associated with Sjögren’s syndrome: A case report with description of the radiologic-pathologic correlation.
  • Diffuse Cystic Lung Disease: Consider Sjögren Syndrome in the Differential Diagnosis.
  • Autoimmune Myelofibrosis in Sjögren’s Syndrome: Report of a Case.
  • A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren’s syndrome.
  • Utility of the EULAR Sjögren syndrome disease activity index in Japanese children: a retrospective multicenter cohort study.
  • [Inflammation in Dry Eye Disease – Information on Diagnostic Testing and Therapy Using the Scientific Online Information Platform OSCB-Berlin.org].
  • LAMP3 induces apoptosis and autoantigen release in Sjögren’s syndrome patients.
  • One year in review 2020: comorbidities, diagnosis and treatment of primary Sjögren’s syndrome.
  • Evaluation of soluble CD25 as a clinical and autoimmune biomarker in primary Sjögren’s syndrome.
  • An objective method of diagnosing hydroxychloroquine maculopathy.
  • Kikuchi-Fujimoto disease associated with primary Sjögren’s syndrome – literature review based on a case report.
  • Mesenchymal stem cell transplantation alleviates experimental Sjögren’s syndrome through IFN-β/IL-27 signaling axis.
  • Hypokalemic paralysis as an initial presentation of Sjogren syndrome.
  • Clinical Study of Jianfei Kangfu Cao in the Treatment of pSS-ILD
  • The BAFF / APRIL system as therapeutic target in multiple sclerosis.
  • Recent Advances in the Use of Exosomes in Sjögren’s Syndrome.
  • Study of Safety and Tolerability of CFZ533 in Patients With Sjögren’s Syndrome
  • A Study on the Relevance of Glucose-6-Phosphate Dehydrogenase Level Screening in Patients with Rheumatic Diseases Prior to Initiating Treatment With Hydroxychloroquine.
  • Molecular Targeting of Immunosuppressants Using a Bifunctional Elastin-Like Polypeptide.
  • The effect of pilocarpine on dental caries in patients with primary Sjögren’s syndrome: a database prospective cohort study.
  • Clinical practice guidance for Sjögren’s syndrome in pediatric patients (2018) – summarized and updated.
  • Immune checkpoint inhibitors-induced autoimmunity: The impact of gender.
  • Transverse myelitis associated with primary biliary cirrhosis: clinical, laboratory, and neuroradiological features.
  • Infections in systemic autoimmune diseases.
  • The challenge of managing comorbidities: a case report of primary Sjogren’s syndrome in a patient with acute intermittent porphyria.
  • Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending.
  • Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors.
  • Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
  • Prognostic factors for primary Sjögren’s syndrome-associated interstitial lung diseases.
  • Characterization of a subset of patients with primary Sjögren’s syndrome initially presenting with C3 or C4 hypocomplementemia.
  • Connective tissue disease–associated interstitial lung disease: an underreported cause of interstitial lung disease in Sub-Saharan Africa.
  • Dental Implants in Sjögren Syndrome.
  • Connective Tissue Disease-Related Interstitial Lung Disease: Prevalence, Patterns, Predictors, Prognosis, and Treatment.
  • Refining myositis associated with primary Sjögren’s syndrome: data from the prospective cohort ASSESS.
  • Cricoarytenoid joint arthritis: a possible complication of dermatomyositis.
  • [Local and systemic light chain amyloidosis in patients with rheumatic diseases].
  • Acute severe sensory ganglionopathy in systemic lupus erythematous.
  • Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
  • Uveal Effusion Syndrome as the Initial Manifestation of Primary Sjögren’s Syndrome and Review of the Literature.
  • Nodular localized primary cutaneous amyloidosis and primary Sjögren’s syndrome.
  • The Valued Life Activities Scale (VLAs): linguistic validation, cultural adaptation and psychometric testing in people with rheumatic and musculoskeletal diseases in the UK.
  • [New directions of pharmacotherapy of immune – inflammatory rheumatic diseases].
  • An Innovative Online Qualitative Study to Explore the Symptom Experience of Patients with Primary Sjögren’s Syndrome.
  • Salivary Biomarkers and Their Application in the Diagnosis and Monitoring of the Most Common Oral Pathologies.
  • Hydroxychloroquine in rheumatic autoimmune disorders and beyond.
  • Corneal In Vivo Laser-Scanning Confocal Microscopy Findings in Dry Eye Patients with Sjögren’s Syndrome.
  • Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases Part 2.
  • A Complex Case of Polymyositis Overlapping With Hypothyroid Myopathy Without Underlying Autoimmune Thyroid Disorder.
  • Axial articular manifestations in primary Sjögren’s syndrome: Association with spondyloarthritis.
  • Multiple sclerosis and neuromyelitis optica after optic neuritis: A nationwide cohort study in Taiwan.
  • Drug-induced Bullous Pemphigoid and Lupus Erythematosus Occurring under Anti-TNF-α and IL-6 Therapy in a Patient with Rheumatoid Arthritis.
  • Lymphangioleiomyomatosis: A Case Report and Review of Clinical Features and Management.
  • Concomitant Sjögren’s Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis.
  • Pulmonary Involvement in a Mouse Model of Sjögren’s Syndrome Induced by STING Activation.
  • Focus on Effects of Chinese Medicine on Improving Anxiety-Depression and Quality of Life of Patients with Primary Sjögren’s Syndrome.
  • Inclusion-body myositis and primary Sjögren syndrome: mechanisms for shared etiologies.
  • Concurrent primary Sjögren’s syndrome and isolated ocular sarcoidosis presenting with bilateral corneal scarring and dry eye.
  • Characteristics of primary Sjögren’s syndrome related lymphocytic interstitial pneumonia.
  • The multifaceted functional role of DNA methylation in immune-mediated rheumatic diseases.
  • [Sjögren’s syndrome with juvenile onset].
  • A Case of Sjögren’s Syndrome as an Immune-related Adverse Event of Nivolumab Treatment for Gastric Cancer.
  • Spontaneous pregnancies in patients with at least one failed IVF cycle after the management of autoimmune disorders, hereditary thrombophilia, and methylation disorders.
  • Coexistence of Sarcoidosis and Sjögren’s syndrome with hypercalcemia and renal involvement: A case report and literature review.
  • Complicated case of Mycobacterium abscessus conjunctivitis in Sjögren’s syndrome.
  • A Tutorial on Saliva’s Role in Swallowing With a Focus on Sjögren’s Syndrome.
  • Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease
  • Articular and Peripheral Nervous System Involvement Are Linked to the Long-Term Outcome in Primary Sjögren’s Syndrome: The Relevance of Single Organ Manifestations Rather Than a Composite Score as Predictors.
  • Nephrological disorders and neurological involvement in pediatric primary Sjogren syndrome:a case report and review of literature.
  • Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren’s syndrome enrolled in a large observational US registry.
  • The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic Diseases
  • Peritoneal Carcinomatosis in an Adult With Sjögren’s Syndrome: A Diagnostic Dilemma Revealing a Rare Association With Primary Gastric Adenocarcinoma.
  • Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab alone.
  • Tirabrutinib: First Approval.
  • Total glucosides of paeony: A review of its phytochemistry, role in autoimmune diseases, and mechanisms of action.
  • Effectiveness of resistance exercise in functional fitness in women with primary Sjögren’s syndrome: randomized clinical trial.
  • Syndrome de Sjögren.
  • Hospital admission for blood collection for the preparation of autologous serum eye drops.
  • Congenital Complete Atrioventricular Heart Block in a Pregnant Woman with Sjögren Syndrome: Prenatal Care Follow-Up and the Challenge of Intrauterine Treatment.
  • Effective Treatment with Tocilizumab in a Rheumatoid Arthritis Patient Complicated with Human T-cell Leukemia Virus Type 1-associated Myelopathy: A Case Report.
  • [Mesenchymal stem cell treatment in autoimmune diseases].
  • Aberrant HLA-DR expression in the conjunctival epithelium after autologous serum treatment in patients with graft-versus-host disease or Sjögren’s syndrome.
  • Lack of Conventional Acinar Cells in Parotid Salivary Gland of Patient Taking an Anti-PD-L1 Immune Checkpoint Inhibitor.
  • Evaluation of the Efficacy and Safety of A Novel 0.05% Cyclosporin A Topical Nanoemulsion in Primary Sjögren’s Syndrome Dry Eye.
  • Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection.
  • Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.
  • Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjögren’s syndrome mouse model.
  • New Viral Facets in Oral Diseases: The EBV Paradox.
  • Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy.
  • Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy.
  • Achaete-Scute Homologue 2-Regulated Follicular Helper T Cells Promote Autoimmunity in a Murine Model for Sjögren Syndrome.
  • [Primary Sjögren’s Syndrome – News on Diagnostics and Therapy].
  • P2 Receptors as Therapeutic Targets in the Salivary Gland: From Physiology to Dysfunction.
  • Complementary therapy with traditional Chinese medicine for a patient with Sjögren’s syndrome: A case report.
  • Pulmonary Involvement in Sjögren Syndrome.
  • [The necessity and importance of standardized diagnosis and treatment of primary Sjögren’s syndrome].
  • [Recommendations of diagnosis and treatment of primary Sjögren’s syndrome in China].
  • Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome
  • Effects of Acupuncture on Sjögren’s Syndrome
  • Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
  • Gene expression profiling of epithelium-associated FcRL4+ B cells in primary Sjögren’s syndrome reveals a pathogenic signature.
  • Shear wave elastography as a new method to identify parotid lymphoma in primary Sjögren Syndrome patients: an observational study.
  • Colchicine as possible treatment of non-cryoglobulinaemic vasculitis in Sjögren’s syndrome.
  • Dual function of miR-1248 links interferon induction and calcium signaling defects in Sjögren’s syndrome.
  • RESET Trial – Part 1 (Followed by Reset Trial – Part 2) – A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)
  • Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjögren’s syndrome.
  • Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy.
  • Recurrent aseptic meningitis: A rare clinical presentation of Sjogren’s syndrome.
  • Hyperkalemia in type 4 renal tubular acidosis associated with systemic lupus erythematosus.
  • [Targeted therapies for connective tissue diseases and vasculitis].
  • Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits.
  • Somatosensory profile of a patient with mixed connective tissue disease and Sjögren syndrome.
  • Severe anemia caused by hereditary hemorrhagic telangiectasia in a patient with Sjögren’s syndrome and primary biliary cirrhosis.
  • Hydroxychloroquine was associated with reduced risk of new-onset diabetes mellitus in patients with Sjögren syndrome.
  • HTLV-1 Infection and Rheumatic Diseases.
  • Stratifying Sjögren syndrome into symptom-based subgroups.
  • Elevated EPSTI1 promote B cell hyperactivation through NF-κB signalling in patients with primary Sjögren’s syndrome.
  • Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren’s syndrome to facilitate their concerted migration.
  • Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report.
  • Characteristics of diffuse large B-cell lymphoma in patients with primary Sjögren’s syndrome.
  • Intravenous immunoglobulin efficacy for primary Sjögren’s Syndrome associated small fiber neuropathy.
  • Characteristics and risk factors for pulmonary arterial hypertension associated with primary Sjögren’s syndrome: 15 new cases from a single center.
  • Association of Sjögren’s syndrome with myotonic dystrophy type 1.
  • Carnitine Palmitoyl Transferase Deficiency in a University Immunology Practice.
  • The Traditional Chinese Medicine Fufang Shatai Heji (STHJ) Enhances Immune Function in Cyclophosphamide-Treated Mice.
  • Sjögren’s Syndrome with Cerebral Venous Sinus Thrombosis: A Case Report and Literature Review.
  • Adolescent Sjogren’s syndrome presenting as psychosis: a case series.
  • Efficacy of dupilumab reveals therapeutic target for IgG4-related disease: simultaneous control of inflammation and fibrosis.
  • [Primary thymic mucosa-associated lymphoid tissue lymphoma: 7 clinical cases report and a review of the literature].
  • Antifibrotics in interstitial lung disease related to connective tissue diseases – a paradigm shift in treatment and outcome.
  • the Effect of Mixture of Natural Products As Salivary Substitutes in Treatment Of Xerostomia
  • Prevalence and clinical presentation of lymphoproliferative disorder in patients with primary Sjögren’s syndrome.
  • Toward better outcomes in Sjögren’s syndrome: The promise of a stratified medicine approach.
  • Emergence of rheumatoid arthritis following exposure to natalizumab.
  • Pulmozyme for Sjogren’s Associated Cough
  • Levocarnitine for Dry Eye in Sjogren’s Syndrome
  • A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome
  • Tolerance and Efficiency of an Intrabuccal Biological Film to Enhance Oral Dryness Sensation: The “PREDELFI” Clinical Pilot Study
  • Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren’s Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis
  • Hyperglycemia and Salivary Gland Dysfunction in the Non-obese Diabetic Mouse: Caveats for Preclinical Studies in Sjögren’s Syndrome.
  • Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry Eye
  • Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren’s syndrome.
  • Overactive bladder and bladder pain syndrome/interstitial cystitis in primary Sjögren’s syndrome patients: A nationwide population-based study.
  • Sweet’s Syndrome Following Therapy with Hydroxychloroquine in a Patient Affected with Elderly-Onset Primary Sjogren’s Syndrome.
  • A 45-Year-Old Woman With Multiple Pulmonary Nodules and Sjögren Syndrome.
  • Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis.
  • Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.
  • The value of MiR-146a and MiR-4484 expressions in the diagnosis of anti-SSA antibody positive Sjogren syndrome and the correlations with prognosis.
  • Prognostic factors for primary Sjögren’s syndrome-associated interstitial lung diseases.
  • Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases
  • Omalizumab for Lupus
  • Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren’s Syndrome
  • Secondary Sjögren syndrome: A case report using silver diamine fluoride and glass ionomer cement.
  • Rituximab-Bendamustine (R-Benda) in MALT lymphoma complicating primary Sjögren syndrome (pSS).
  • Increased risk of aortic aneurysm and dissection in patients with Sjögren’s syndrome: a nationwide population-based cohort study in Taiwan.
  • Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease
  • Associations between Antibiotics for Non-tuberculous Mycobacterial Infection and Incident Sjögren’s Syndrome: A Nationwide, Population-based Case-control Study.
  • Nivolumab in Treating Patients With Autoimmune Disorders or Advanced, Metastatic, or Unresectable Cancer
  • A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts

www.SjogrensTreatmentReport.com

All rights reserved